Guarneri, Valentina <br/><br/>
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Jul 2010 
 - 181-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-010-0866-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab<br/>Breast Neoplasms--complications<br/>Diphosphonates--adverse effects<br/>Docetaxel<br/>Double-Blind Method<br/>Drug Synergism<br/>Female<br/>Genes, erbB-2<br/>Humans<br/>Incidence<br/>Jaw Diseases--chemically induced<br/>Middle Aged<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Neoplasm Metastasis<br/>Oral Hygiene<br/>Osteonecrosis--chemically induced<br/>Paclitaxel--administration & dosage<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Taxoids--administration & dosage<br/>Vinblastine--administration & dosage<br/>Vinorelbine